{"log_id": 196672139792228939, "direction": 0, "words_result_num": 76, "words_result": [{"probability": {"variance": 0.001388, "average": 0.983456, "min": 0.857378}, "location": {"width": 234, "top": 171, "height": 23, "left": 107}, "words": "核准日期:2007年03月06日"}, {"probability": {"variance": 0.000881, "average": 0.990301, "min": 0.875931}, "location": {"width": 235, "top": 193, "height": 29, "left": 105}, "words": "修改日期:2009年03月20日"}, {"probability": {"variance": 0.000225, "average": 0.99343, "min": 0.938677}, "location": {"width": 233, "top": 220, "height": 23, "left": 107}, "words": "修改日期:2010年10月01日"}, {"probability": {"variance": 0.009543, "average": 0.962623, "min": 0.704167}, "location": {"width": 197, "top": 255, "height": 38, "left": 512}, "words": "来氟米特片说明书"}, {"probability": {"variance": 0.000134, "average": 0.995105, "min": 0.961271}, "location": {"width": 307, "top": 288, "height": 29, "left": 445}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 0, "average": 0.999682, "min": 0.999214}, "location": {"width": 97, "top": 320, "height": 25, "left": 111}, "words": "【药品名称】"}, {"probability": {"variance": 0.000125, "average": 0.995044, "min": 0.962119}, "location": {"width": 179, "top": 342, "height": 23, "left": 146}, "words": "通用名称:来氟米特片"}, {"probability": {"variance": 1.4e-05, "average": 0.99735, "min": 0.989265}, "location": {"width": 145, "top": 367, "height": 22, "left": 145}, "words": "商品名称:爱若华"}, {"probability": {"variance": 0, "average": 0.999262, "min": 0.99877}, "location": {"width": 71, "top": 390, "height": 19, "left": 147}, "words": "英文名称"}, {"probability": {"variance": 0.000168, "average": 0.992576, "min": 0.961824}, "location": {"width": 194, "top": 410, "height": 22, "left": 145}, "words": "汉语拼音: Laifumite Piar"}, {"probability": {"variance": 0.002361, "average": 0.982498, "min": 0.815168}, "location": {"width": 224, "top": 432, "height": 24, "left": 110}, "words": "【成份】主要成份为来氟米特"}, {"probability": {"variance": 0, "average": 0.999724, "min": 0.999496}, "location": {"width": 104, "top": 456, "height": 19, "left": 147}, "words": "其化学名称为"}, {"probability": {"variance": 0.009426, "average": 0.947217, "min": 0.62881}, "location": {"width": 277, "top": 447, "height": 27, "left": 316}, "words": "氟-5-甲基-异唑-N-酰基-对甲苯胺"}, {"probability": {"variance": 0, "average": 0.999613, "min": 0.999231}, "location": {"width": 122, "top": 477, "height": 22, "left": 147}, "words": "其化学结构式为"}, {"probability": {"variance": 0.017468, "average": 0.948242, "min": 0.467046}, "location": {"width": 165, "top": 520, "height": 21, "left": 145}, "words": "分子式:C12HgF3N2O2"}, {"probability": {"variance": 0.000266, "average": 0.988838, "min": 0.94807}, "location": {"width": 108, "top": 543, "height": 20, "left": 145}, "words": "分子量:270.2"}, {"probability": {"variance": 6.5e-05, "average": 0.995168, "min": 0.965986}, "location": {"width": 350, "top": 557, "height": 32, "left": 110}, "words": "【性状】本品为薄膜衣片,除去包衣后显白色"}, {"probability": {"variance": 0.002282, "average": 0.987661, "min": 0.714663}, "location": {"width": 572, "top": 576, "height": 34, "left": 111}, "words": "适应症】(1)适用于成人类风湿关节炎,有改善病情作用。(2)狼疮性肾炎"}, {"probability": {"variance": 0.000189, "average": 0.988351, "min": 0.956334}, "location": {"width": 104, "top": 610, "height": 20, "left": 109}, "words": "【规格】(1)10"}, {"probability": {"variance": 0.000125, "average": 0.985224, "min": 0.966342}, "location": {"width": 35, "top": 610, "height": 16, "left": 269}, "words": "(2)2"}, {"probability": {"variance": 1.3e-05, "average": 0.996087, "min": 0.989338}, "location": {"width": 85, "top": 631, "height": 20, "left": 118}, "words": "用法用量】"}, {"probability": {"variance": 0.00269, "average": 0.983612, "min": 0.669512}, "location": {"width": 988, "top": 637, "height": 67, "left": 96}, "words": "临、(1)成人类风湿关节炎:口服。由于来氟米特半衰期较长,建议间隔24小时给药。为了快速达到稳态血药浓度,参照国外"}, {"probability": {"variance": 0.002742, "average": 0.987987, "min": 0.67335}, "location": {"width": 693, "top": 662, "height": 36, "left": 102}, "words": "临床试验资料并结合I期临床试验结果,建议开始治疗的最初三天给予负荷剂量一日50"}, {"probability": {"variance": 7e-06, "average": 0.99788, "min": 0.992615}, "location": {"width": 251, "top": 661, "height": 25, "left": 831}, "words": "之后根据病情给予维持剂量一日"}, {"probability": {"variance": 0.000513, "average": 0.991059, "min": 0.885469}, "location": {"width": 682, "top": 684, "height": 40, "left": 101}, "words": "1mg或20mg在使用本药治疗期间可继续使用非甾体抗炎药或低剂量皮质类固醇激素"}, {"probability": {"variance": 0.000263, "average": 0.992657, "min": 0.920044}, "location": {"width": 619, "top": 708, "height": 34, "left": 142}, "words": "2)狼疮性肾炎:口服。根据病情选择适当剂量,推荐剂量一日一次,一次20-40"}, {"probability": {"variance": 0.006985, "average": 0.96508, "min": 0.66082}, "location": {"width": 285, "top": 705, "height": 22, "left": 798}, "words": "病情缓解后适当减量。可与糖皮质激"}, {"probability": {"variance": 3.3e-05, "average": 0.996946, "min": 0.981704}, "location": {"width": 141, "top": 740, "height": 21, "left": 101}, "words": "素联用,或遵医嘱"}, {"probability": {"variance": 1e-06, "average": 0.999407, "min": 0.997348}, "location": {"width": 88, "top": 761, "height": 23, "left": 115}, "words": "不良反应】"}, {"probability": {"variance": 0.002365, "average": 0.991056, "min": 0.635422}, "location": {"width": 931, "top": 769, "height": 36, "left": 138}, "words": "用于类风湿性关节炎的治疗:主要有腹泻、瘙痒、可逆性肝脏前(ALT和AST)升高、脱发、皮疹等。在国外临床试验中"}, {"probability": {"variance": 0.000697, "average": 0.993795, "min": 0.802089}, "location": {"width": 983, "top": 790, "height": 39, "left": 98}, "words": "来氟米特治疗1339例类风湿关节炎病人中,发生率≥3%的不良事件包括:乏力、腹痛、背痛、高血压、厌食、腹泻、消化不"}, {"probability": {"variance": 0.002616, "average": 0.990092, "min": 0.620713}, "location": {"width": 983, "top": 813, "height": 37, "left": 99}, "words": "良、胃肠炎、肝脏前升高、恶心、口腔溃疡、呕吐、体重减轻、关节功能障碍、腱鞘炎、头晕、头痛、支气管炎、咳嗽、呼吸"}, {"probability": {"variance": 6.4e-05, "average": 0.996817, "min": 0.956066}, "location": {"width": 984, "top": 835, "height": 37, "left": 97}, "words": "道感染、咽炎、脱发、瘙痒、皮疹、泌尿系统感染等。以上不良事件均在安慰剂对照或阳性对照柳氮磺胺吡啶治疗组及MTX"}, {"probability": {"variance": 0.001027, "average": 0.988623, "min": 0.844519}, "location": {"width": 840, "top": 859, "height": 35, "left": 97}, "words": "治疗组中发现,其中来氟米特治疗组以腹泻、肝脏酶升高、脱发、皮疹较为明显,在应用过程中应加以注意"}, {"probability": {"variance": 0.002623, "average": 0.980516, "min": 0.756428}, "location": {"width": 500, "top": 884, "height": 32, "left": 137}, "words": "用于狼疮性肾炎的治疗:国内临床试验资料显示来氟米特治疗"}, {"probability": {"variance": 0.001655, "average": 0.986928, "min": 0.795449}, "location": {"width": 395, "top": 881, "height": 23, "left": 682}, "words": "例活动增殖型狼疮肾炎病人中,前6个月(2040mg"}, {"probability": {"variance": 0.018488, "average": 0.953265, "min": 0.432272}, "location": {"width": 495, "top": 906, "height": 33, "left": 100}, "words": "日),共有43人发生与试验药物可能有关/有关的不良反应发生"}, {"probability": {"variance": 0.000541, "average": 0.993035, "min": 0.8853}, "location": {"width": 395, "top": 901, "height": 28, "left": 679}, "words": "%;治疗期间,发生率≥3%的不良事件包括:脱发"}, {"probability": {"variance": 0.015064, "average": 0.955725, "min": 0.572484}, "location": {"width": 513, "top": 927, "height": 36, "left": 98}, "words": "血压升高、带状疱疹、转氨酶升高、腹泻/稀使、白细胞下降皮"}, {"probability": {"variance": 5e-05, "average": 0.996373, "min": 0.969225}, "location": {"width": 388, "top": 925, "height": 25, "left": 676}, "words": "不调、心悸、腹痛;发生率<3%的不良事件包括"}, {"probability": {"variance": 0.002598, "average": 0.984682, "min": 0.720389}, "location": {"width": 985, "top": 945, "height": 39, "left": 97}, "words": "恶心呕吐、上呼吸道感染、血小板下降、乏力、胃烧灼感、厌食、发热、周疼痛、视觉异常、尿路感染、咽痛、巨细胞病毒"}, {"probability": {"variance": 0.006013, "average": 0.972607, "min": 0.570057}, "location": {"width": 982, "top": 966, "height": 39, "left": 97}, "words": "感染、体重下降、多毛、肺部感染等。治疗7-72月1030mg/日),随访52例患者,共有12人发生与试验药物可能有关有关"}, {"probability": {"variance": 0.00737, "average": 0.966601, "min": 0.552201}, "location": {"width": 986, "top": 988, "height": 40, "left": 95}, "words": "的不良反应,发生率为23.08%,发生率≥3%的不度事件包括:白细胞下转氨酶升高、血小板减少:发生率<3%的不良事"}, {"probability": {"variance": 0.0093, "average": 0.970692, "min": 0.500037}, "location": {"width": 563, "top": 1015, "height": 34, "left": 95}, "words": "件包括:上呼吸道感染、脱发、带状疱疹、月经不调尿路感染。心"}, {"probability": {"variance": 0.007581, "average": 0.976064, "min": 0.572678}, "location": {"width": 475, "top": 1039, "height": 32, "left": 104}, "words": "【禁忌】对本品及其代谢产物过敏者及严重肝脏损害患者禁用"}, {"probability": {"variance": 0.003812, "average": 0.981206, "min": 0.611048}, "location": {"width": 974, "top": 1054, "height": 38, "left": 104}, "words": "【注意事项】(1)临床试验发现来氟米特可引起一过性的ALT升高和白细胞降,服药初始阶段应定期检查ALT和白细胞。检"}, {"probability": {"variance": 7e-06, "average": 0.997557, "min": 0.991446}, "location": {"width": 178, "top": 1089, "height": 26, "left": 95}, "words": "查间隔视病人情况而定"}, {"probability": {"variance": 0, "average": 0.457442, "min": 0.457442}, "location": {"width": 18, "top": 1085, "height": 16, "left": 616}, "words": " gt"}, {"probability": {"variance": 7.9e-05, "average": 0.997178, "min": 0.937583}, "location": {"width": 942, "top": 1097, "height": 38, "left": 137}, "words": "()有肝脏损害和明确的乙肝或丙肝血清学指标阳性的患者慎用。用药前及用药后每月检查ALT,检测时间间隔视病人具"}, {"probability": {"variance": 0.000356, "average": 0.994892, "min": 0.868683}, "location": {"width": 966, "top": 1121, "height": 37, "left": 95}, "words": "体情况而定。如果用药期间出现ALT升高,调整剂量或中断治疗的原则:①如果ALT升高在正常值的2倍(<80U/L)以内"}, {"probability": {"variance": 0.002307, "average": 0.984364, "min": 0.71997}, "location": {"width": 983, "top": 1142, "height": 37, "left": 94}, "words": "继续观察。②如果ALT升高在正常值的2-3倍之间(80-120U/L),减半量服用,继续观察,若ALT继续升高或仍然维持80-120U"}, {"probability": {"variance": 0.000949, "average": 0.989668, "min": 0.826576}, "location": {"width": 959, "top": 1164, "height": 36, "left": 104}, "words": "L之间,应中断治疗。③如果ALT升高超过正常值的3倍(>120U/L),应停药观察。停药后若ALT恢复正常可继续用药"}, {"probability": {"variance": 9.6e-05, "average": 0.995277, "min": 0.958469}, "location": {"width": 436, "top": 1191, "height": 33, "left": 96}, "words": "同时加强护肝治疗及随访,多数病人ALT不会再次升高"}, {"probability": {"variance": 0.000191, "average": 0.994452, "min": 0.928891}, "location": {"width": 677, "top": 1209, "height": 37, "left": 133}, "words": "()免疫缺陷、未控制的感染、活动性胃肠道疾病、肾功能不全、骨髓发育不良( bone ma"}, {"probability": {"variance": 0.000449, "average": 0.974721, "min": 0.941657}, "location": {"width": 157, "top": 1210, "height": 23, "left": 854}, "words": " dysplasia)的患者慎用"}, {"probability": {"variance": 0.002372, "average": 0.988622, "min": 0.642915}, "location": {"width": 940, "top": 1229, "height": 37, "left": 136}, "words": "4)如果服药期间出现白细胞下降,调整剂量或中断治疗的原则如下:①若白细胞不低于3.0×109/L,继续服药观察。②"}, {"probability": {"variance": 0.009262, "average": 0.965108, "min": 0.470388}, "location": {"width": 985, "top": 1252, "height": 38, "left": 92}, "words": "若白细胞在2.0×109/L~3.0×10°/L之间,减半量服药观察。继续用药期间,多数病人可以恢复正常。若复查白细胞仍低于3.0×109"}, {"probability": {"variance": 0.00751, "average": 0.964636, "min": 0.603923}, "location": {"width": 622, "top": 1277, "height": 35, "left": 94}, "words": "/L,中断服药。③若白细胞低于2.0×10°/L,中断服药。建议粒细胞计数不低于"}, {"probability": {"variance": 0.036786, "average": 0.851974, "min": 0.479507}, "location": {"width": 37, "top": 1279, "height": 19, "left": 757}, "words": "10°/L"}, {"probability": {"variance": 0.001509, "average": 0.98344, "min": 0.818143}, "location": {"width": 495, "top": 1300, "height": 33, "left": 135}, "words": "5)准备生育的男性应考虑中断服药,同时服用考来烯胺(消胆胺"}, {"probability": {"variance": 0.000161, "average": 0.996182, "min": 0.917395}, "location": {"width": 794, "top": 1318, "height": 39, "left": 133}, "words": "6)在本品治疗期间接种免疫活疫苗的效果和安全性没有临床资料,因此服药期间不应使用免疫活疫苗"}, {"probability": {"variance": 2.4e-05, "average": 0.997696, "min": 0.970914}, "location": {"width": 720, "top": 1340, "height": 36, "left": 133}, "words": "7)据国外报道,该药在国外上市后罕见间质性肺炎的发生,有肺部疾患者,请慎用或遵医嘱"}, {"probability": {"variance": 9e-06, "average": 0.998547, "min": 0.984848}, "location": {"width": 664, "top": 1362, "height": 35, "left": 110}, "words": "孕妇及哺乳期妇女用药】孕妇及尚未采取可靠避孕措施的育龄妇女及哺乳期妇女禁用"}, {"probability": {"variance": 4e-06, "average": 0.998983, "min": 0.990017}, "location": {"width": 805, "top": 1383, "height": 36, "left": 103}, "words": "儿童用药】对儿童应用本品的疗效和安全性还没有研究,故年龄小于18岁的患者,建议不要使用本品"}, {"probability": {"variance": 1e-06, "average": 0.998968, "min": 0.996171}, "location": {"width": 360, "top": 1413, "height": 28, "left": 110}, "words": "老年用药】未进行该项实验且无可靠参考文献"}, {"probability": {"variance": 1e-06, "average": 0.998696, "min": 0.997035}, "location": {"width": 121, "top": 1439, "height": 22, "left": 105}, "words": "药物相互作用】"}, {"probability": {"variance": 0.023152, "average": 0.936356, "min": 0.563707}, "location": {"width": 128, "top": 1459, "height": 26, "left": 129}, "words": "据文献资料报道"}, {"probability": {"variance": 0.006448, "average": 0.980505, "min": 0.47196}, "location": {"width": 779, "top": 1470, "height": 39, "left": 129}, "words": "()考来烯胺和活性炭13例患者和96例志愿者给予考来烯胺或活性炭,血浆中MI浓度很快减少"}, {"probability": {"variance": 0.002503, "average": 0.985245, "min": 0.669734}, "location": {"width": 944, "top": 1490, "height": 38, "left": 131}, "words": "2)肝毒性药物来氟米特和其它肝毒性药物合用可能增加不良反应,同时也应考虑到虽然中断来氟米特治疗,但没有采"}, {"probability": {"variance": 0.001232, "average": 0.989233, "min": 0.78935}, "location": {"width": 966, "top": 1509, "height": 44, "left": 88}, "words": "取药物消除措施就接着服用这些药物,同样有可能增加不良反应。在小样本(30例)来氟米特和MTX联合用药的研究中,有"}, {"probability": {"variance": 0.000808, "average": 0.990842, "min": 0.81021}, "location": {"width": 979, "top": 1535, "height": 37, "left": 88}, "words": "例肝脏酶出现2-3倍升高。其中2例继续服用,3例中断来氟米特治疗,酶的升高都得到恢复。另外5例升高大于3倍,其中2"}, {"probability": {"variance": 0.006851, "average": 0.979376, "min": 0.559897}, "location": {"width": 482, "top": 1561, "height": 33, "left": 88}, "words": "例继续服用,3例中断来氟米特治疗,酶的升高也都得到恢复"}, {"probability": {"variance": 0.002489, "average": 0.9858, "min": 0.643909}, "location": {"width": 945, "top": 1577, "height": 37, "left": 128}, "words": "()非甾体抗炎药物在体外一系列临床研究中,Ml可使血浆游离双氯芬酸和布洛芬的浓度升高13%50%,此临床意义"}, {"probability": {"variance": 1.2e-05, "average": 0.998233, "min": 0.98255}, "location": {"width": 735, "top": 1602, "height": 35, "left": 87}, "words": "还不清楚。但在临床试验中曾观察了许多和非甾体药物同时应用的病例,没有发现有特殊影响"}, {"probability": {"variance": 0.003399, "average": 0.981859, "min": 0.610549}, "location": {"width": 907, "top": 1621, "height": 38, "left": 126}, "words": "()甲苯磺丁脲在一系列临床研究中发现,M]可使血浆游离甲苯磺丁脲浓度升高13%-50%,此临床意义还不清楚"}, {"probability": {"variance": 0.022612, "average": 0.898612, "min": 0.564553}, "location": {"width": 83, "top": 1686, "height": 22, "left": 538}, "words": "第-1-2-页"}], "language": 3}